Vivian Wu | executive |
Howard W. Robin | executive |
Jonathan Zalevsky | executive |
Mary Tagliaferri | executive |
Sandra Gardiner | executive |
Jay Olson | analyst |
Kambiz Yazdi | analyst |
Tsan-Yu Hsieh | analyst |
Good day, and thank you for standing by. Welcome to the Nektar Therapeutics Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.